InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Cohen Cheryl, Directeur. Director active across 2 companies, notably Aerpio Pharmaceuticals, Inc.. Cumulatively, 8 disclosures have been published. Split: 0 buy · 5 sells. Total volume traded: €2m. Activity tracked since 30 June 2021. The latest transaction was disclosed on 2 July 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations8 total
55,979 shares@ US$2.98Common StockSEC:0001529371-26-000008:0
131,210 shares@ US$9.5034Common StockSEC:0001529371-26-000008:1
9,976 shares@ US$10.00480.0010% mcap9.3% of flowCommon StockSEC:0001209191-21-053210:0
9,976 shares@ US$10.00489.3% of flowCommon StockSEC:0001209191-21-053210
43,398 shares@ US$10.12440.7% of flowCommon StockSEC:0001209191-21-052660
43,398 shares@ US$10.1240.0045% mcap40.7% of flowCommon StockSEC:0001209191-21-052660:0
8,140 shares@ US$1.5250.0% of flowCommon StockSEC:0000899243-21-027281
8,140 shares@ US$1.5250.0% of flowCommon StockSEC:0000899243-21-027281:0
8 of 8 declarations
About Cohen Cheryl
Cheryl Cohen is a Director at Aerpio Pharmaceuticals, Inc. and ImmunityBio, Inc. She plays a key role in the strategic direction of these companies, bringing her expertise to guide development and growth initiatives.
